ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

Nurse Oncology Society Growing, developing Care Guidelines

August 19, 1977

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

June 24, 2011

DCBDC To Contract For CA Agents In Vaccine Testing

November 15, 1991

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012